drugset

drugset / Trial / NCT06976489

The Food Effect on PK Characteristics and Safety Profiles of PA-111

NCT06976489 ↗

Phase 1 Not yet recruiting 40 enrolled Addpharma Inc.

RandomizedCrossoverOpen-labelTreatment

Summary

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.

Timeline

Start: 2025-05
Primary completion: 2025-07
Completion: 2025-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PA-111	Unknown	—	Oral

Indications